DropsDrops
Schedule H (Prescription Required)Anti-Allergy & Anti-Inflammatory DropsCode: 2317

Fluromethalone 0.1% w/v Eye Drop 5ml

Generic Formulation:Fluromethalone 0.1% w/v Eye Drop 5ml
Pack Size:5ml Drop bottle in Mono Carton
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹28.13
Brand Estimate*
₹154.55
Estimated Savings:₹126.42 (82% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Fluorometholone (0.1% w/v ophthalmic suspension) is a surface-active fluorinated synthetic topical corticosteroid. It undergoes rapid enzymatic metabolism in the anterior chamber, conferring robust anti-inflammatory relief of conjunctival and superficial corneal inflammation while possessing significantly lower propensity to elevate intraocular pressure than dexamethasone or prednisolone. Indicated for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2317.Report inaccuracy

Usage Guidelines

Shake suspension well before instillation. Instill one drop into conjunctival sac 2 to 4 times daily.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Mild stinging, burning, conjunctival redness. Rare/Severe: Elevated IOP (less common than prednisolone), corneal ulceration, and cataract.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in viral, mycobacterial, or fungal ocular infections. Taper dose gradually. Regular IOP checks recommended for courses exceeding 10 days.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or ophthalmic treatment recommendations. Always consult a registered ophthalmologist or ENT specialist before initiating, changing, or instilling any ophthalmic or otic medication.